France will end healthcare refunds for homeopathic drugs
PARIS (Reuters) – France will end social security reimbursements for homeopathic drugs and the new policy – which has drawn the fire of alternative medicine advocates – will take full…
France will end healthcare refunds for homeopathic drugs – minister
FILE PHOTO: Agnes Buzyn, French Minister for Solidarity and Health arrives for a meeting at the Elysee Palace in Paris, France, January 11, 2019. REUTERS/Benoit Tessier PARIS (Reuters) – France…
Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage
(Reuters) – Novartis AG (NOVN.S) said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local pharmacies across the United States, as a shortage of Mylan…
Novartis to sell epinephrine injector in U.S. pharmacies amid EpiPen shortage
FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo (Reuters)…
U.S. recorded 18 new cases of measles last week
FILE PHOTO: Lead medical assistant Fengmei Lin holds a vial of the measles, mumps, and rubella virus (MMR) vaccine at the International Community Health Services clinic in Seattle, Washington, U.S.,…
FDA ties three deaths to Edwards Lifesciences’ recalled heart devices
(Reuters) – The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp’s recall of some of its heart devices. The agency…
Teen vaping on the rise in U.S, Canada
More American and Canadian teens are vaping than ever before, according to a new study, and researchers say the availability of e-cigarettes with more nicotine may partly explain the trend.…
Sarepta surges after Pfizer gene therapy data raises safety concerns
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) surged 15% on Friday after some safety concerns were raised in a small, early-stage study of a competing gene therapy for a…
Oklahoma judge approves Teva’s $85 million opioid settlement
(Reuters) – An Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd resolving claims by the state’s attorney general that the drugmaker…
Oklahoma judge approves Teva’s $85 million opioid settlement
(Reuters) – An Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd resolving claims by the state’s attorney general that the drugmaker…